A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
Conditions: Malignant Neoplasm Interventions: Drug: TSN1611 Sponsors: Tyligand Bioscience (Shanghai) Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
A Study of TSN084 in Patients With Advanced Malignant Tumors
Conditions: Malignant Neoplasm Interventions: Drug: TSN084 Sponsors: Tyligand Bioscience (Shanghai) Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
RC48 Combined With Adebrelimab and Apatinib and S-1 of the Neoadjuvant Therapy of Locally Advanced Gastric Cancer
Conditions: Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Interventions: Drug: RC48; Drug: Adebrelimab; Drug: Apatinib; Drug: S-1 Sponsors: The First Affiliated Hospital with Nanjing Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
A Clinical Study of HMPL-506 in Patients With Hematological Malignancies
Conditions: Hematological Malignancies Interventions: Drug: HMPL-506 Sponsors: Hutchmed Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)
Conditions: Esophageal Cancer Interventions: Drug: neoadjuvant anti-PD-1; Drug: neoadjuvant anti-PD-1 with LDRT Sponsors: Shanghai Chest Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDer
Conditions: Endometrial Cancer Interventions: Drug: Lurbinectedin; Drug: Dostarlimab Sponsors: Vall d ' Hebron Institute of Oncology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
HER-TEMPO - Real World Treatment-related Outcomes on T-DXd in Canada
Conditions: Unresectable Breast Cancer; Metastatic Breast Cancer; HER2-low Expressing Breast Cancer; HER2-positive Breast Cancer Interventions: Drug: Trastuzumab deruxtecan Sponsors: AstraZeneca; Daiichi Sankyo Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Study Evaluating the Efficacy of the myDIET Software Tool in the Nutritional Management of Patients With Localized and Resectable Gastric or Esogastric Junction Cancer.
Conditions: Gastric Cancer; Oesogastric Junction Cancer Interventions: Other: myDIET software tool Sponsors: Centre Leon Berard Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
TOP 2301: Neoadjuvant Chemo for NSCLC
Conditions: Non Small Cell Lung Cancer Interventions: Drug: Alirocumab; Drug: Cemiplimab; Drug: Chemotherapy Sponsors: Duke University; Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Fluorouracil Treatment Via Colon for Colorectal Cancer
Conditions: Colorectal Cancer Interventions: Drug: Colonic local administration of fluorouracil with enhanced adhesion Sponsors: The Second Hospital of Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Prospective Multicenter Cohort Study to Validate Four Groups of Biomarkers for Assessing Lung Cancer Risk Among Patients With Atheromatous Cardiovascular Disease in a Screening Pathway
Conditions: Smoking-related Pathology; Atheroma; Non-progressive Cancer> 5 Years; Lung Cancer Interventions: Diagnostic Test: blood sampling; Diagnostic Test: stool collection; Radiation: low dose CT scan Sponsors: Assistance Publique Hopitaux De Marseille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer
Conditions: Esophagus Cancer Interventions: Radiation: chemo-radiation Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer
Conditions: Ovarian Cancer; Postoperative Complications; Neoadjuvant Therapy; Lymph Node Excision Interventions: Procedure: lymphadenectomy Sponsors: Tongji Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy
Conditions: Triple Negative Breast Neoplasms Interventions: Drug: UTD1 Sponsors: Hunan Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
Registry of Patients Undergoing Cryoablation for Early Stage Breast Cancer
Conditions: Early Stage Breast Carcinoma Interventions: Other: Non-Interventional Study Sponsors: Jonsson Comprehensive Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 26, 2024 Category: Research Source Type: clinical trials
